Clinical guidelines «Polycystic Ovary Syndrome»-Reference-Cited by-同舟云学术

Clinical guidelines «Polycystic Ovary Syndrome»

Published:2022-02-06 Issue:2 Volume:68 Page:112-127
ISSN:2308-1430
Container-title:Problems of Endocrinology
language:
Short-container-title:Probl Endokrinol (Mosk)

Author:

Adamyan L. V.¹^ORCID,Andreeva E. N.²^ORCID,Absatarova Yu. S.³^ORCID,Grigoryan O. R.³^ORCID,Dedov I. I.³^ORCID,Melnichenko G. A.³^ORCID,Suturina L. V.⁴^ORCID,Filippov O. S.⁵,Sheremetyeva E. V.³^ORCID,Chernukha G. E.⁶^ORCID,Yarmolinskaya M. I.⁷^ORCID

Affiliation:

1. National Medical Research Center of Obstetrics, Gynecology and Perinatology; Moscow State University of Medicine and Dentistry of A.I. Evdokimov

2. Endocrinology research centre; Moscow State University of Medicine and Dentistry of A.I. Evdokimov

3. Endocrinology research centre

4. Scientific Center for Family Health and Human Reproduction Problems

5. I.M. Sechenov First Moscow State Medical University (Sechenov University); Ministry of Health of the Russian Federation

6. National Medical Research Center of Obstetrics, Gynecology and Perinatology

7. Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott; North-Western State Medical University named after I.I. Mechnikov

Abstract

Polycystic ovary syndrome (PCOS) is a polygenic endocrine disorder caused by both genetic and epigenetic factors. Depending on the period of a woman’s life, the clinical picture, diagnosis, and treatment tactics of the disease are different. PCOS has a complex of reproductive, metabolic and psychological characteristics. The target audience of these clinical recommendations are obstetrician-gynecologists, endocrinologists, general practitioners, general practitioners. In these clinical guidelines, all information is ranked according to the level of persuasiveness of recommendations and the reliability of evidence, depending on the number and quality of studies on this issue.

Publisher

Endocrinology Research Centre

Subject

Endocrinology, Diabetes and Metabolism

Reference125 articles.

1. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364-379. doi: https://doi.org/10.1016/j.fertnstert.2018.05.004

2. Goodman NF, Cobin RH, Futterweit W, et al. American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2. Endocr Pract. 2015;21(12):1415-1426. doi: https://doi.org/10.4158/EP15748.DSCPT2

3. Randeva HS, Tan BK, Weickert MO, et al. Cardiometabolic Aspects of the Polycystic Ovary Syndrome. Endocr Rev. 2012;33(5):812-841. doi: https://doi.org/10.1210/er.2012-1003

4. Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Prim. 2016;2(1):16057. doi: https://doi.org/10.1038/nrdp.2016.57.

5. Neven A, Laven J, Teede H, Boyle J. A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines. Semin Reprod Med. 2018;36(01):5-12. doi: https://doi.org/10.1055/s-0038-1668085

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of the Gut Microbiota in Patients with Polycystic Ovary Syndrome;Annals of the Russian academy of medical sciences;2023-11-01